Endothelin in pulmonary fibrosis.
暂无分享,去创建一个
[1] K. Kubo,et al. Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats , 2009, European Respiratory Journal.
[2] T. Carpenter,et al. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[3] M. Burdick,et al. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis , 2009, Journal of leukocyte biology.
[4] A. Prasse,et al. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. , 2009, Respiratory medicine.
[5] T. Sugiyama,et al. Involvement of NADPH oxidase and protein kinase C in endothelin-1-induced superoxide production in retinal microvessels. , 2009, Experimental eye research.
[6] David S. Rogers,et al. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. , 2009, American journal of respiratory cell and molecular biology.
[7] Aalt Bast,et al. Telomere shortening in chronic obstructive pulmonary disease. , 2009, Respiratory medicine.
[8] Zhongjie Sun,et al. Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors. , 2008, Endocrinology.
[9] P. Lansdorp,et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.
[10] Nitin Patel,et al. Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha. , 2008, Blood.
[11] Xiaohong Yan,et al. Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes. , 2008, Canadian journal of physiology and pharmacology.
[12] S. Rankin. Impact of bone marrow on respiratory disease. , 2008, Current opinion in pharmacology.
[13] R. Strieter. What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. , 2008, Proceedings of the American Thoracic Society.
[14] R. Chambers. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? , 2008, British journal of pharmacology.
[15] C. Marsh,et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. , 2008, Antioxidants & redox signaling.
[16] K. Kuwano,et al. Dual-immunohistochemistry provides little evidence for epithelial–mesenchymal transition in pulmonary fibrosis , 2008, Histochemistry and Cell Biology.
[17] R. D. du Bois,et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. , 2007, Arthritis and rheumatism.
[18] M. Iglarz,et al. Mechanisms of ET-1-induced Endothelial Dysfunction , 2007, Journal of cardiovascular pharmacology.
[19] G. Laurent,et al. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? , 2007, European Respiratory Journal.
[20] N. Kaminski,et al. Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis1 , 2007, The Journal of Immunology.
[21] David Abraham,et al. Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions , 2007, Arthritis research & therapy.
[22] J. Norris,et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.
[23] P. Shaul,et al. Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. , 2007, American journal of respiratory cell and molecular biology.
[24] Chao Xing,et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.
[25] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[26] J. McArthur,et al. Molecular programming of endothelin‐1 in HIV‐infected brain: role of Tat in up‐regulation of ET‐1 and its inhibition by statins , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] M. Clozel,et al. Endothelin receptors as drug targets in chronic cardiovascular diseases: the rationale for dual antagonism , 2006 .
[28] K. Brown,et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. , 2006, American journal of respiratory and critical care medicine.
[29] D. Sheppard,et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.
[30] R. Hubbard,et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK , 2006, Thorax.
[31] R. D. du Bois,et al. Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors , 2006, Molecular and Cellular Biology.
[32] J. Horowitz,et al. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. , 2006, Proceedings of the American Thoracic Society.
[33] S. Phan,et al. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. , 2006, Proceedings of the American Thoracic Society.
[34] Johny Verschakelen,et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.
[35] J. Egan,et al. Herpesviruses: a cofactor in the pathogenesis of idiopathic pulmonary fibrosis? , 2005, American journal of physiology. Lung cellular and molecular physiology.
[36] D. Radisky. Epithelial-mesenchymal transition , 2005, Journal of Cell Science.
[37] T. Oury,et al. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.
[38] P. Grammas,et al. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. , 2005, Biochemical and biophysical research communications.
[39] K. Csiszȧr,et al. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis , 2005, Arthritis research & therapy.
[40] R. Mason,et al. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.
[41] M. Rojas,et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.
[42] A. Nicholson,et al. Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells by Transforming Growth Factor-β1 : Potential Role in Idiopathic Pulmonary Fibrosis , 2005 .
[43] M. Clozel,et al. Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan , 2005, Annals of medicine.
[44] Q. Xie,et al. RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro , 2004 .
[45] M. Redondo-Horcajo,et al. Transforming Growth Factor-β Induces Endothelin-1 Expression Through Activation of the Smad Signaling Pathway , 2004 .
[46] K. Brown,et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. , 2004, American journal of respiratory and critical care medicine.
[47] E. Renzoni. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? , 2004, American journal of respiratory and critical care medicine.
[48] Yunliang Chen,et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. , 2004, Molecular biology of the cell.
[49] R. D. du Bois,et al. Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK* , 2004, Journal of Biological Chemistry.
[50] P. Thompson,et al. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL‐induced apoptosis , 2004, The Journal of pathology.
[51] F. Martinez,et al. Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.
[52] S. Phan,et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.
[53] R. Kalluri,et al. Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.
[54] D. Abraham,et al. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[55] K. Stenmark,et al. Endothelin B Receptor Deficiency Predisposes to Pulmonary Edema Formation via Increased Lung Vascular Endothelial Cell Growth Factor Expression , 2003, Circulation research.
[56] Santiago Lamas,et al. Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-&bgr;–Mediated Induction of Endothelin-1 Expression , 2003, Circulation research.
[57] D. Rockey,et al. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. , 2003, Molecular biology of the cell.
[58] A. Nicholson,et al. Interstitial vascularity in fibrosing alveolitis. , 2003, American journal of respiratory and critical care medicine.
[59] V. Poletti,et al. Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63 , 2002, Laboratory Investigation.
[60] A. Nicholson,et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.
[61] B. Hinz,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.
[62] M. Niwa,et al. Endothelin-1 Binding to Endothelin Receptors in the Rat Anterior Pituitary Gland: Possible Formation of an ETA–ETB Receptor Heterodimer , 2002, Cellular and Molecular Neurobiology.
[63] I. D. Johnston,et al. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002 .
[64] R. Silver,et al. Thrombin Differentiates Normal Lung Fibroblasts to a Myofibroblast Phenotype via the Proteolytically Activated Receptor-1 and a Protein Kinase C-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[65] W. Thurlbeck,et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. , 2001, American journal of respiratory and critical care medicine.
[66] S. Wedgwood,et al. Role for Endothelin-1-Induced Superoxide and Peroxynitrite Production in Rebound Pulmonary Hypertension Associated With Inhaled Nitric Oxide Therapy , 2001, Circulation research.
[67] P. Enright,et al. An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern italy. , 2001, Chest.
[68] J. Pearson,et al. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. , 2001, The Journal of investigative dermatology.
[69] D. Rodman,et al. Role of endothelin-1 in lung disease , 2001, Respiratory research.
[70] F. Askin,et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. , 2001, The New England journal of medicine.
[71] A. Pardo,et al. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.
[72] M. Kasper,et al. Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat , 2000, Histochemistry and Cell Biology.
[73] G. Taraboletti,et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 2000, The American journal of pathology.
[74] K. Chida,et al. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. , 2000, Thorax.
[75] K. Stenmark,et al. Endothelin receptor blockade decreases lung water in young rats exposed to viral infection and hypoxia. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[76] H. Neumayer,et al. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. , 2000, American Journal of Respiratory Cell and Molecular Biology.
[77] R. Samransamruajkit,et al. Modulation of endothelin-1 expression in pulmonary epithelial cell line (A549) after exposure to RSV. , 2000, International journal of molecular medicine.
[78] R. Ardaillou,et al. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. , 1999, Circulation.
[79] Y. Schwarz,et al. Effect of endothelin-1 on α-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases , 1999 .
[80] G. Gabbiani,et al. Mechanisms of myofibroblast activity and phenotypic modulation. , 1999, Experimental cell research.
[81] A. Woodcock,et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. , 1999, American journal of respiratory and critical care medicine.
[82] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[83] R. Lockey,et al. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. , 1998, Biochemical and biophysical research communications.
[84] R. Chambers,et al. Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats. , 1998, American journal of respiratory cell and molecular biology.
[85] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[86] N. Goldsack,et al. Effect of endothelin receptor antagonists (BQ-485, Ro 47-0203) on collagen deposition during the development of bleomycin-induced pulmonary fibrosis in rats. , 1998, Pulmonary pharmacology & therapeutics.
[87] M. Stacey,et al. Endothelin-1 Induces Bronchial Myofibroblast Differentiation , 1997, Peptides.
[88] J A Waldron,et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[89] J. Fiet,et al. Endothelin-1 secretion by alveolar macrophages in systemic sclerosis. , 1997, American journal of respiratory and critical care medicine.
[90] R. D. du Bois,et al. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. , 1997, The American journal of pathology.
[91] A. Venuti,et al. The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop , 1997, Journal of virology.
[92] R. Michel,et al. Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. , 1997, American journal of respiratory and critical care medicine.
[93] A. Woodcock,et al. Viruses and idiopathic pulmonary fibrosis. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[94] J. Fiet,et al. IL-1 beta inhibits ET-1 production by ATII cells in vitro: evidence for involvement of cyclooxygenase 2 pathway. , 1997, The American journal of physiology.
[95] D. Hansell,et al. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. , 1997, American journal of respiratory and critical care medicine.
[96] B. Corrin,et al. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. , 1997, American journal of respiratory cell and molecular biology.
[97] R. McAnulty,et al. Changes in collagen metabolism in response to endothelin-1: evidence for fibroblast heterogeneity. , 1996, The international journal of biochemistry & cell biology.
[98] A. Desmoulière,et al. Factors influencing myofibroblast differentiation during wound healing and fibrosis. , 1995, Cell biology international.
[99] L. Fasano,et al. Endothelin-1 in idiopathic pulmonary fibrosis. , 1995, Journal of clinical pathology.
[100] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[101] M. Polokoff,et al. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.
[102] M. Yamaguchi,et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. , 1994, American journal of respiratory and critical care medicine.
[103] G. Laurent,et al. Characterization of fibroblast mitogens and chemoattractants produced by endothelial cells exposed to hypoxia. , 1994, American journal of respiratory cell and molecular biology.
[104] K. Weber,et al. Effects of endothelins on collagen turnover in cardiac fibroblasts. , 1993, Cardiovascular research.
[105] M. Sheppard,et al. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis , 1993, The Lancet.
[106] G. Laurent,et al. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. , 1992, American journal of respiratory cell and molecular biology.
[107] C. Guidry,et al. Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts , 1991, The Journal of cell biology.
[108] S. Nakanishi,et al. Cloning and expression of human endothelin‐1 receptor cDNA , 1991, FEBS letters.
[109] M. Kahaleh,et al. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. , 1991, Arthritis and rheumatism.
[110] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[111] R. Rodríguez-Roisín,et al. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis , 1985, The Journal of pathology.
[112] A. Katzenstein. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. , 1985, Human pathology.
[113] R. Pokela,et al. Ultrastructure of terminal respiratory epithelium and prognosis in chronic interstitial pneumonia. , 1980, European journal of respiratory diseases.
[114] I. Adamson,et al. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. , 1974, The American journal of pathology.
[115] M. Turner‐Warwick. SYSTEMIC ARTERIAL PATTERNS IN THE LUNG AND CLUBBING OF THE FINGERS. , 1963, Thorax.
[116] M. Selman,et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. , 2008, The international journal of biochemistry & cell biology.
[117] A. Halayko,et al. Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[118] R. Kedzierski,et al. Endothelin system: the double-edged sword in health and disease. , 2001, Annual review of pharmacology and toxicology.
[119] U. Sack,et al. Different Expression of Endothelin in the Bronchoalveolar Lavage in Patients with Pulmonary Diseases , 2001, Lung.
[120] M. Mcmillen,et al. Endothelins are angiogenic. , 2000, Journal of cardiovascular pharmacology.